Categories Multiple Myeloma

CAR T-cell Therapy Industry Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics …

CAR T-cell Therapy Industry Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics … “ The CAR T-cell Therapy Industry Market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2016-2025. On the basis of historical data, CAR T-cell Therapy Industry Market report provides key segments and their […]

Read More
Categories Multiple Myeloma

US Small Molecule Targeted Cancer Therapy Market: Technological Advancement, Challenges …

US Small Molecule Targeted Cancer Therapy Market: Technological Advancement, Challenges … Overview Of Small Molecule Targeted Cancer Therapy Industry 2021-2028: This has brought along several changes in This report also covers the impact of COVID-19 on the global market. The Small Molecule Targeted Cancer Therapy Market Report a detailed study of different aspects of the […]

Read More
Categories Multiple Myeloma

Multiple Myeloma Drugs Market: Revenue Analysis Forecast 2020-2025

Multiple Myeloma Drugs Market: Revenue Analysis Forecast 2020-2025 According to the latest report by IMARC Group, titled “Multiple Myeloma Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global multiple myeloma drugs market grew at a CAGR of around 9% during 2014-2019. . It causes cancer cells to produce abnormal proteins that […]

Read More
Categories Multiple Myeloma

Hydrocortisone Market With Top Countries data : Evolving Technology, Trends and Industry …

Hydrocortisone Market With Top Countries data : Evolving Technology, Trends and Industry … The “Hydrocortisone Market” Research Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and […]

Read More
Categories Multiple Myeloma

Cipla spurts on settling litigation with Celgene Corp for cancer drug Revlimid

Cipla spurts on settling litigation with Celgene Corp for cancer drug Revlimid Cipla rose 3.70% to Rs 783.85 after the drug major announced the settlement of its litigation with Celgene Corporation relating to patents for Revlimid (lenalidomide). In the US, Revlimid (lenalidomide) in combination with dexamethasone is indicated for the treatment of patients with multiple […]

Read More
Categories Multiple Myeloma

Analysts Expect Sutro Biopharma, Inc. (NASDAQ:STRO) Will Announce Quarterly Sales of $12.60 …

Analysts Expect Sutro Biopharma, Inc. (NASDAQ:STRO) Will Announce Quarterly Sales of $12.60 … Equities analysts expect that Sutro Biopharma, Inc. (NASDAQ:STRO) will post $12.60 million in sales for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Sutro Biopharma’s earnings, with estimates ranging from $7.00 million to $19.54 million. Sutro Biopharma reported […]

Read More